{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:48:51Z","timestamp":1780350531825,"version":"3.54.1"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 (HD081296)"],"award-info":[{"award-number":["R01 (HD081296)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 (U54HD090259)"],"award-info":[{"award-number":["U54 (U54HD090259)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CER\u20101602\u20133447"],"award-info":[{"award-number":["CER\u20101602\u20133447"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the administration of intravenous immunoglobulin (<jats:styled-content style=\"fixed-case\">IVI<\/jats:styled-content>g) at a dose of 2 g\/kg, approximately 3\u20135% of children with acute Kawasaki disease (<jats:styled-content style=\"fixed-case\">KD<\/jats:styled-content>) may develop coronary artery aneurysms. <jats:styled-content style=\"fixed-case\">IVI<\/jats:styled-content>g\u2010resistance, defined as recrudescence of fever more than 36 h after <jats:styled-content style=\"fixed-case\">IVI<\/jats:styled-content>g completion, is a risk factor for coronary artery abnormalities. Thus, several adjunctive therapies are being evaluated for use in <jats:styled-content style=\"fixed-case\">IVI<\/jats:styled-content>g\u2010resistant <jats:styled-content style=\"fixed-case\">KD<\/jats:styled-content> patients and in patients with coronary artery abnormalities. In this review the role of some of these adjunctive therapies in treatment of children with <jats:styled-content style=\"fixed-case\">KD<\/jats:styled-content> is discussed.<\/jats:p>","DOI":"10.1111\/1756-185x.13208","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T12:22:41Z","timestamp":1509106961000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Adjunctive therapies in Kawasaki disease"],"prefix":"10.1111","volume":"21","author":[{"given":"Adriana H.","family":"Tremoulet","sequence":"first","affiliation":[{"name":"Kawasaki Disease Research Center University of California San Diego La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.12.021"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592865"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.03.050"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0223-z"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318266bcf9"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.03.025"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061235"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951114002601"},{"issue":"2","key":"e_1_2_4_10_1","first-page":"332","article-title":"Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease","volume":"66","author":"Kobayashi T","year":"2008","journal-title":"Nippon Rinsho"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0223-z"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61930-2"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-008-0727-9"},{"issue":"1","key":"e_1_2_4_14_1","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial","volume":"129","author":"Ogata S","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"e_1_2_4_15_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk\u2010scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper LA","year":"2011","journal-title":"J Pediatr"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000045"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2016.46.4.542"},{"issue":"2","key":"e_1_2_4_18_1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","article-title":"Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta\u2010analysis","volume":"99","author":"Chen S","year":"2013","journal-title":"Heart"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(88)90088-8"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90166-N"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.12.022"},{"issue":"1","key":"e_1_2_4_22_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-10-28","article-title":"Catastrophic Kawasaki disease unresponsive to IVIG in a 3\u2010month\u2010old infant: a diagnostic and therapeutic challenge","volume":"10","author":"Magalhaes CM","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62298-9"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.06.011"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.10.012"},{"issue":"7","key":"e_1_2_4_26_1","first-page":"748","article-title":"The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases","volume":"20","author":"Peyre M","year":"2013","journal-title":"Arch Pediatr"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.06.014"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.02.048"},{"issue":"9","key":"e_1_2_4_29_1","first-page":"1636","article-title":"Cyclosporin A treatment for refractory Kawasaki disease","volume":"72","author":"Suzuki H","year":"2014","journal-title":"Nihon Rinsho"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009562"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e3181f52a7f"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-013-0746-9"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04331.x"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-011-0623-0"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.109"},{"issue":"1","key":"e_1_2_4_36_1","first-page":"16","article-title":"Transforming growth factor\u2010beta signaling pathway in patients with Kawasaki disease","volume":"4","author":"Shimizu C","year":"2011","journal-title":"Circulation"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.05.004"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2007.05.006"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.310233"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2015.1066246"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901395"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.072769"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0102-6"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.13208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:32:06Z","timestamp":1695893526000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/1756-185X.13208"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13208","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]},"assertion":[{"value":"2017-10-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}